China CRO Partners
BC-BIOSTAT Co., Ltd.
BC-Biostat provides a range of professional services for Phase I to Phase IV clinical trials, especially in Data Management, Statistics, Medical Writing, Regulatory Affairs and risk based clinical operations of drug, medical device and any health products. We are committed to providing start to end clinical trial management, analysis and reporting services for the Pharmaceutical and medical device industry in China and the world.
Beijing Trust Medicine Consulting Ltd.
Our mission is to provide professional clinical data management, statistical analysis, quality management and consulting services for pharmaceutical companies and clinical research institutes. We also provide consulting service for GMP, GSP, GLP, GPP, and GAP certification, professional training, auditing, consultancy, conceptual design, GEP management declaration and registration submission. Since inception, Trust has been committed to providing professional drug development services with high quality and high efficiency, adding value to risk management, cost saving and marketing process expediting.
Guangzhou Jeeyor Medical Research Co.,Ltd. was created in june 2012. It is the first CRO that focused on clinical trial data management and biostatistics in south of China. Jeeyor relies on the best statistical institutions: Southern Medical University, Sichuan University, Guangzhou University of Chinese Medicine etc. We closely tracking and grasp the global latest data management and biostatistics norms and standards to build our core service capability. Jeeyor is aimed at providing “standard, professional, fast, intimate” data management and biostatistics services for pharmaceutical enterprises and investigator – both at home and abroad.
Meta Clinical Technology Co. Ltd is a Contract Research Organization (CRO) with its focus on outsourced biometrics businesses related to clinical trials that are sponsored by domestic or global pharmaceutical companies. It has offices located in Shanghai, Beijing, Xi’an and Shenyang in China, and has built a partnership with Beijing Clinical Service Center (BCSC), which is a full service CRO in China. So far, Meta-Clinical has provided the service of data management, biostatistics, and pharmacovigilance in bioequivalence, Phase I-IV, and post-approval clinical trials of innovative and generic drugs for numerous global/domestic pharmaceutical companies.
Beijing Maiconside was founded in 2007 and is an internationalized contract service organization (CRO). With Beijing as the center, McConstant established branch offices in Guangzhou, Tianjin and other places to provide domestic and foreign pharmaceutical companies and biopharmaceutical companies with one-stop technology for pharmacokinetics, bioanalysis and early clinical trials that meet international standards. service.
The opportunities for drug and device manufacturers in China are matched only by the challenges that are also unique to China. That’s why it’s of growing importance to work with a CRO that is local to the area that understands how to navigate through the obstacles and take full advantage of the opportunities. R&G will: Promise top quality deliverables- every time, expedite timelines, and provide you with innovative and cost-effective solutions. R&G also has a strong track record for high quality deliverables and services, an extensive knowledge of the local clinical trial environment, and have formed great working relationships with local Sites and KOL through years of experience conducting clinical trials across the whole country.